## Clinical Diagnosis: Status Epilepticus (SE) **Key Point:** Status epilepticus is defined as ≥2 seizures without return to baseline consciousness between them, or continuous seizure activity lasting ≥5 minutes. This patient meets the definition with 4 GTCS in 2 hours. ### Pathophysiology of SE **High-Yield:** Prolonged seizure activity causes: - Cerebral metabolic exhaustion (glucose, oxygen depletion) - Loss of cerebral autoregulation → cerebral edema - Hyperthermia, rhabdomyolysis, acute kidney injury - GABA~A~ receptor desensitization → reduced benzodiazepine efficacy if seizures persist >30 min This is a medical emergency with mortality 10–15% if untreated. ### Treatment Algorithm for SE ```mermaid flowchart TD A[Status Epilepticus diagnosed]:::urgent --> B[Secure airway, 100% O2]:::action B --> C[IV access, labs, glucose check]:::action C --> D[First-line: IV Benzodiazepine]:::action D --> E[Lorazepam 4 mg IV or Diazepam 10 mg IV]:::action E --> F{Seizures stopped?}:::decision F -->|Yes| G[Load 2nd-line AED]:::action F -->|No| H[Repeat BZD dose at 10-15 min]:::action G --> I[Phenytoin 15-20 mg/kg IV at <50 mg/min]:::action H --> I I --> J{Still seizing?}:::decision J -->|Yes| K[Intubate + ICU]:::urgent J -->|No| L[Continue maintenance AED]:::action ``` ### Why Lorazepam 4 mg IV? | Feature | Lorazepam | Diazepam | Phenytoin alone | |---------|-----------|----------|------------------| | **Onset** | 1–3 min IV | 1–5 min IV | 10–20 min IV | | **Duration** | 12–24 hours | 15–60 min | Days (long-acting) | | **SE efficacy** | 65–80% | 40–60% | Not monotherapy | | **Respiratory depression** | Moderate | High | Minimal | | **Preferred in SE** | **Yes** | Alternative | 2nd-line only | **Clinical Pearl:** Lorazepam is superior to diazepam in SE because of longer CNS half-life and more sustained seizure suppression. Diazepam redistributes rapidly, causing brief seizure control followed by recurrence. ### Why NOT phenytoin monotherapy (Option B)? 1. **Slow onset:** 10–20 min even at IV administration. Patient is actively seizing NOW. 2. **Infusion rate critical:** Must infuse at <50 mg/min (slower in elderly/cardiac disease) to avoid hypotension, arrhythmias, and purple glove syndrome. 3. **Benzodiazepine is first-line:** ILAE and American Epilepsy Society guidelines mandate IV benzodiazepine as first-line for SE, followed by second-line AED (phenytoin, levetiracetam, or valproate). **Warning:** Phenytoin at 100 mg/min (Option B) risks severe hypotension, bradycardia, and cardiac arrhythmias — contraindicated in acute SE. ### Correct Sequence 1. **Immediate:** Lorazepam 4 mg IV (or diazepam 10 mg IV if lorazepam unavailable) 2. **Simultaneously:** Secure airway, 100% O~2~, IV access, blood glucose, labs 3. **At 5–10 min:** If seizures persist, repeat benzodiazepine dose 4. **At 10–20 min:** Load phenytoin 15–20 mg/kg IV at <50 mg/min (or levetiracetam 30–60 mg/kg, or valproate 15–20 mg/kg) 5. **At 30–60 min:** If still seizing, intubate and transfer to ICU for continuous infusion (propofol, midazolam, or pentobarbital) **High-Yield:** The patient's non-compliance with phenytoin is the likely trigger. Abrupt AED withdrawal is a major cause of SE in known epilepsy. ### Why Not Option C (Diazepam + observe)? While diazepam is acceptable, **observing for 30 minutes is dangerous** — SE is a medical emergency requiring aggressive management. Delaying second-line AED loading increases risk of refractory SE and brain damage. ### Why Not Option D (Levetiracetam monotherapy)? Levetiracetam is a valid **second-line** AED but NOT first-line for SE. Benzodiazepine must precede any AED. Levetiracetam alone has slower onset and lower efficacy in acute SE compared to lorazepam. ## Summary **Correct answer: Lorazepam 4 mg IV + phenytoin loading** follows ILAE/AES guidelines for SE management and provides rapid seizure suppression with sustained effect.
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.